glutamine has been researched along with 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brueggen, J; Friedlos, F; Marais, R; Matter, A; Maycroft, K; O'Reilly, T; Roussel, J; Spooner, RA; Springer, CJ; Stolz, B; Stribbling, SM; Wood, J | 1 |
1 other study(ies) available for glutamine and 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid
Article | Year |
---|---|
A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs.
Topics: Adenocarcinoma; Endothelial Growth Factors; Endothelium; Female; gamma-Glutamyl Hydrolase; Glutamates; Glutamine; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Mutagenesis, Site-Directed; Neovascularization, Pathologic; Nitrogen Mustard Compounds; Ovarian Neoplasms; Plasmids; Point Mutation; Prodrugs; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2003 |